Precision Biosensor Balance Sheet Health
Financial Health criteria checks 3/6
Precision Biosensor has a total shareholder equity of ₩29.9B and total debt of ₩15.6B, which brings its debt-to-equity ratio to 52%. Its total assets and total liabilities are ₩56.0B and ₩26.0B respectively.
Key information
52.0%
Debt to equity ratio
₩15.57b
Debt
| Interest coverage ratio | n/a |
| Cash | ₩5.78b |
| Equity | ₩29.94b |
| Total liabilities | ₩26.03b |
| Total assets | ₩55.97b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: A335810's short term assets (₩17.5B) exceed its short term liabilities (₩5.8B).
Long Term Liabilities: A335810's short term assets (₩17.5B) do not cover its long term liabilities (₩20.2B).
Debt to Equity History and Analysis
Debt Level: A335810's net debt to equity ratio (32.7%) is considered satisfactory.
Reducing Debt: A335810's debt to equity ratio has reduced from 89.4% to 52% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A335810 has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: A335810 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 11.1% each year